Abstract:Although the use of bioresorbable materials in stent production is thought to improve long-term safety compared to their durable counterparts, a recent FDA report on the 2-year follow-up of the first FDA-approved bioresorbable vascular stent showed an increased occurrence of major adverse cardiac events and thrombosis in comparison to the metallic control. In order to overcome the issues of first generation bioresorbable polymers, a series of polyethylene glycol-functionalized poly-L-lactide-co-ε-caprolactone copolymers with varying lactide-to-caprolactone content is developed using a novel one-step PEG-functionalization and copolymerization strategy. This approach represents a new facile way toward surface enhancement for cellular interaction, which is shown by screening these materials regarding their cyto- and hemocompatibility in terms of cytotoxicity, hemolysis, platelet adhesion, leucocyte activation and endothelial cell adhesion. By varying the lactide-to-caprolactone polymer composition, it is possible to gradually affect endothelial and platelet adhesion which allows fine-tuning of the biological response based on polymer chemistry. All polymers developed were non-cytotoxic, had acceptable leucocyte activation levels and presented non-hemolytic (<2% hemolysis rate) behavior except for PLCL-PEG 55:45 which presented hemolysis rate of 2.5% ± 0.5. Water contact angles were reduced in the polymers containing PEG functionalization (PLLA-PEG: 69.8° ± 2.3, PCL-PEG: 61.2° ± 7.5) versus those without (PLLA: 79.5° ± 3.2, PCL: 76.4° ± 10.2) while the materials PCL-PEG550, PLCL-PEG550 90:10 and PLCL-PEG550 70:30 demonstrated best endothelial cell adhesion. PLLA-PEG550 and PLCL-PEG550 70:30 presented as best candidates for cardiovascular implant use from a cytocompatibility perspective across the spectrum of testing completed. Altogether, these polymers are excellent innovative materials suited for an application in stent manufacture due to the ease in translation of this one-step synthesis strategy to device production and their excellent in vitro cyto- and hemocompatibility.

The Fabrication and Properties of Co-polymer Poly (Lactic-Co-glycolic Acid) Ureteral Stent by Electrospining

Degradable Antimicrobial Ureteral Stent Construction with Silver@graphdiyne Nanocomposite

CONTROL OF DIMENSIONAL STABILITY AND DEGRADATION RATE IN ELECTROSPUN COMPOSITE SCAFFOLDS COMPOSED OF POLY(D,L-LACTIDE-co-GLYCOLIDE) AND POLY(ε-CAPROLACTONE)

[Preliminary Evaluation of the Biological Properties of Poly-Lactide-co-glycolic Acid (PLGA) Knitted Mesh].

Biodegradable cross-linked poly(L-lactide-co-ε-caprolactone) networks for ureteral stent formed by gamma irradiation under vacuum

Electrospun biocompatible stent with antibacterial property from shape memory polyurethane/gallic acid

In Vitro Hydrolytic and Enzymatic Degradation of Nestlike-Patterned Electrospun Poly(d,l-Lactide-co-glycolide) Scaffolds.

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

A new hydrophilic biodegradable ureteral stent restrain encrustation both in vitro and in vivo

In Vitro Degradation of Poly[(L‐lactide)‐co‐(trimethylene Carbonate)] Copolymers and a Composite with Poly[(L‐lactide)‐co‐glycolide] Fibers As Cardiovascular Stent Material

Improved Mechanical Properties of Poly( L ‐lactic Acid) Stent Coated by Poly( D , L ‐lactic Acid) and Poly( L ‐lactic‐co‐glycolic Acid) Biopolymer Blend

In vitro degradation and biocompatibility evaluation of fully biobased thermoplastic elastomers consisting of poly(β-myrcene) and poly( -lactide) as stent coating

Degradation and Characterisation of Electrospun Polycaprolactone (PCL) and Poly(lactic-co-glycolic acid) (PLGA) Scaffolds for Vascular Tissue Engineering

Artificial Coronary Vascular Stents Fabrication Using Biodegradable Material Compounds of PLA/PGA-co-Chitosan

PLLA/HA Electrospin Hybrid Nanofiber Scaffolds: Morphology, In Vitro Degradation and Cell Culture Potential

In Vitro Degradation Behavior of L-Lactide/Trimethylene Carbonate/Glycolide Terpolymers and A Composite with Poly(L-Lactide-Co-Glycolide) Fibers

Biodegradation Characteristics of a New Kind of Drug-Eluting Biodegradable Ureteral Stent in Vivo and in Vitro

3D printed peripheral vascular stents based on degradable poly(trimethylene carbonate-b-(L-lactide-ran-glycolide)) terpolymer

Degradation behavior of polylactic‐co‐glycolic acid and polycaprolactone with nanosilver scaffolds

A hazardous boundary of Poly(L-lactic acid) braided stent design: Limited elastic deformability of polymer materials

In Vivo Degradation of Copolymers Prepared from L-Lactide, 1,3-Trimethylene Carbonate and Glycolide As Coronary Stent Materials